Agomir-331 Suppresses Reactive Gliosis and Neuroinflammation after Traumatic Brain Injury

Jin-Xing Wang,Xiao Xiao,Xuan-Cheng He,Bao-Dong He,Chang-Mei Liu,Zhao-Qian Teng
DOI: https://doi.org/10.3390/cells12202429
IF: 6
2023-10-12
Cells
Abstract:Traumatic brain injury usually triggers glial scar formation, neuroinflammation, and neurodegeneration. However, the molecular mechanisms underlying these pathological features are largely unknown. Using a mouse model of hippocampal stab injury (HSI), we observed that miR-331, a brain-enriched microRNA, was significantly downregulated in the early stage (0–7 days) of HSI. Intranasal administration of agomir-331, an upgraded product of miR-331 mimics, suppressed reactive gliosis and neuronal apoptosis and improved cognitive function in HSI mice. Finally, we identified IL-1β as a direct downstream target of miR-331, and agomir-331 treatment significantly reduced IL-1β levels in the hippocampus after acute injury. Our findings highlight, for the first time, agomir-331 as a pivotal neuroprotective agent for early rehabilitation of HSI.
cell biology
What problem does this paper attempt to address?